Loading...
Talkspace, Inc.
TALKW•NASDAQ
Healthcare
Medical - Care Facilities
$0.07
$-0.00(-5.80%)
Talkspace, Inc. (TALKW) Financial Performance & Income Statement Overview
Review Talkspace, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
25.02%
↑ 25.02%
Operating Income Growth
80.62%
↑ 80.62%
Net Income Growth
70.08%
↑ 70.08%
Operating Cash Flow Growth
171.40%
↑ 171.40%
Operating Margin
-2.01%
↓ 2.008%
Gross Margin
44.96%
↑ 44.96%
Net Profit Margin
-2.22%
↓ 2.22%
ROE
-3.73%
↓ 3.73%
ROIC
-3.39%
↓ 3.39%
Talkspace, Inc. (TALKW) Income Statement & Financial Overview
Review Talkspace, Inc.'s (TALKW) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $48.72M | $47.40M | $46.06M | $45.42M |
| Cost of Revenue | $27.19M | $25.78M | $25.11M | $23.68M |
| Gross Profit | $21.53M | $21.62M | $20.95M | $21.73M |
| Gross Profit Ratio | $0.44 | $0.46 | $0.45 | $0.48 |
| R&D Expenses | $2.26M | $2.35M | $2.16M | $3.74M |
| SG&A Expenses | $16.97M | $17.49M | $22.27M | $19.67M |
| Operating Expenses | $20.96M | $21.52M | $24.44M | $23.41M |
| Total Costs & Expenses | $48.15M | $47.30M | $49.54M | $47.09M |
| Interest Income | $0.00 | $1.70M | $3.04M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $231000.00 | $220000.00 | $201000.00 |
| EBITDA | $569000.00 | $99000.00 | -$3.49M | -$1.48M |
| EBITDA Ratio | $0.01 | $0.002 | -$0.07 | -$0.03 |
| Operating Income | $569000.00 | $99000.00 | -$3.49M | -$1.68M |
| Operating Income Ratio | $0.01 | $0.002 | -$0.08 | -$0.04 |
| Other Income/Expenses (Net) | $616000.00 | $1.70M | $3.04M | $378000.00 |
| Income Before Tax | $1.19M | $1.80M | -$442000.00 | -$1.30M |
| Income Before Tax Ratio | $0.02 | $0.04 | -$0.010 | -$0.03 |
| Income Tax Expense | -$29000.00 | -$74000.00 | $32000.00 | $165000.00 |
| Net Income | -$616000.00 | -$1.70M | -$474000.00 | -$1.47M |
| Net Income Ratio | -$0.01 | -$0.04 | -$0.01 | -$0.03 |
| EPS | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Avg Shares Outstanding | $169.20B | $168.43B | $169.15B | $168.85B |
| Weighted Avg Shares Outstanding (Diluted) | $176.71B | $176.23B | $169.15B | $168.85B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan